(Q24815250)

4 July 2017

Correlation between PSMA and VEGF expression as markers for LNCaP tumor angiogenesis (English)

1 reference

4 July 2017

1 reference

Paulus Tsui

1

1 reference

4 July 2017

Marvin Rubenstein

series ordinal

2

1 reference

4 July 2017

Patrick Guinan

series ordinal

3

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of Biomedicine and Biotechnology

4 July 2017

1 reference

4 July 2017

2005

1 reference

4 July 2017

3

1 reference

4 July 2017

287-290

1 reference

Creative Commons Attribution 3.0 Unported

4 July 2017

start time

1 January 2005

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

7 April 2017

Cancer statistics, 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Follow-up evaluation of a phase II prostate cancer vaccine trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1224693

Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model

31 May 2018

1 reference

12 December 2020

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1 reference

12 December 2020

Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice

1 reference

12 December 2020

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

12 December 2020

Dendritic cell-based immunotherapy of prostate cancer

1 reference

12 December 2020

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

1 reference

12 December 2020

Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue

1 reference

12 December 2020

Identifiers

DOI

10.1155/JBB.2005.287

1 reference

4 July 2017

1 reference

4 July 2017

1 reference